CIPLA's weekly performance was disappointing, with a return of -1.62% and a Sharpe Ratio of -0.34, indicating poor risk-adjusted returns. The stock's volatility was high at 18.89%, making it a risky investment this week. Compared to its peers, CIPLA underperformed SUNPHARMA and DIVISLAB, but outperformed GRASIM. Overall, CIPLA's weekly performance was lackluster and volatile.

[Volatility: 18.89%]